136 related articles for article (PubMed ID: 10764707)
21. Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study.
Lin KY; Cheng SM; Tsai SL; Tsai JY; Lin CH; Cheung CH
Onco Targets Ther; 2016; 9():2601-13. PubMed ID: 27217778
[TBL] [Abstract][Full Text] [Related]
22. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells.
Sam S; Sam MR; Esmaeillou M; Safaralizadeh R
Pathol Oncol Res; 2016 Oct; 22(4):715-23. PubMed ID: 27055667
[TBL] [Abstract][Full Text] [Related]
23. Targeting Cell Survival Proteins for Cancer Cell Death.
Pandey MK; Prasad S; Tyagi AK; Deb L; Huang J; Karelia DN; Amin SG; Aggarwal BB
Pharmaceuticals (Basel); 2016 Feb; 9(1):. PubMed ID: 26927133
[TBL] [Abstract][Full Text] [Related]
24. Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.
Tóth C; Meinrath J; Herpel E; Derix J; Fries J; Buettner R; Schirmacher P; Heikaus S
J Cancer Res Clin Oncol; 2016 May; 142(5):927-35. PubMed ID: 26721253
[TBL] [Abstract][Full Text] [Related]
25. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
Sam MR; Ahangar P; Nejati V; Habibian R
Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
[TBL] [Abstract][Full Text] [Related]
26. Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.
Goričar K; Kovač V; Franko A; Dodič-Fikfak M; Dolžan V
Dis Markers; 2015; 2015():316739. PubMed ID: 26451067
[TBL] [Abstract][Full Text] [Related]
27. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
29. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis.
He C; Liu Z; Ji J; Zhu H
Int J Clin Exp Med; 2015; 8(4):5847-54. PubMed ID: 26131175
[TBL] [Abstract][Full Text] [Related]
31. Survivin: A molecular biomarker in cancer.
Jaiswal PK; Goel A; Mittal RD
Indian J Med Res; 2015 Apr; 141(4):389-97. PubMed ID: 26112839
[TBL] [Abstract][Full Text] [Related]
32. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of antagonistic effects of metformin with Cisplatin in gastric cancer cells.
Lesan V; Ghaffari SH; Salaramoli J; Heidari M; Rostami M; Alimoghaddam K; Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res; 2014 Jul; 8(3):12-9. PubMed ID: 25642303
[TBL] [Abstract][Full Text] [Related]
34. Prodigiosin isolated from cell wall of Serratia marcescens alters expression of apoptosis-related genes and increases apoptosis in colorectal cancer cells.
Hassankhani R; Sam MR; Esmaeilou M; Ahangar P
Med Oncol; 2015 Jan; 32(1):366. PubMed ID: 25429836
[TBL] [Abstract][Full Text] [Related]
35. Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.
Wagner V; Hose D; Seckinger A; Weiz L; Meißner T; Rème T; Breitkreutz I; Podar K; Ho AD; Goldschmidt H; Krämer A; Klein B; Raab MS
Oncotarget; 2014 Nov; 5(21):10237-50. PubMed ID: 25296978
[TBL] [Abstract][Full Text] [Related]
36. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?
Nigam J; Chandra A; Kazmi HR; Parmar D; Singh D; Gupta V; M N
Tumour Biol; 2014 Sep; 35(9):9241-6. PubMed ID: 24935470
[TBL] [Abstract][Full Text] [Related]
37. YM155 reverses rapamycin resistance in renal cancer by decreasing survivin.
Koike H; Nitta T; Sekine Y; Arai S; Furuya Y; Nomura M; Matsui H; Shibata Y; Ito K; Oyama T; Suzuki K
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1705-13. PubMed ID: 24916171
[TBL] [Abstract][Full Text] [Related]
38. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
Goossens-Beumer IJ; Zeestraten EC; Benard A; Christen T; Reimers MS; Keijzer R; Sier CF; Liefers GJ; Morreau H; Putter H; Vahrmeijer AL; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jun; 110(12):2935-44. PubMed ID: 24786601
[TBL] [Abstract][Full Text] [Related]
39. Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression.
Kim SA; Hong R
Oncol Lett; 2014 May; 7(5):1589-1593. PubMed ID: 24765182
[TBL] [Abstract][Full Text] [Related]
40. Influence of survivin-targeted siRNA on the biological features of colorectal carcinoma cells.
Xiong Y; Guo W; Li T; Li K
Front Med China; 2007 Jul; 1(3):304-7. PubMed ID: 24573871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
